IMPLANTABLE  CELL  THERAPY  PLATFORM

ImmunoRec is a University of Crete spin-off Biotech Company.

Our Implantable Cell Therapy Platform technology is the offspring of a 15-year research, with 2 major therapeutic applications:

•   Fully Personalized Treatment against Solid tumors

•   Anti-virus prophylactic vaccination

ImmunoRec’s groundbreaking technology of implantable combined Advanced Therapy Medicinal Product (cATMP) leads to the in vivo formation of a non-biodegraded, sustainable, vascularized Artificial Functional Lymph Node.

ImmunoREC

Therapeutic Applications

Fully Personalized Treatment against Solid tumors

                   Anti-viral prophylactic vaccination

ImmunoREC Impact

  • Applied and clinical research concerning Immunorec’s Implantable Cell Therapy Platform technology and its applications in fully personalized anti-tumor treatment and the prophylactic anti-virus vaccination.
  • Organization of scientific meetings, conferences, seminars and training workshops in Greece and abroad.
  • Undertaking scientific works, protocols and others research projects upon request of natural or legal persons of the public or private sector, nationally or internationally.
  • Creation, development, distribution and support of all above services.
  • Participation in local, national, European and international research or other purposes programs for further developing its activity.
  • Scientific consulting services in Immunology.
  • Services of specified diagnosis
ImmunoRec.gr Logo

Stay in touch with our company